Plinabulin iv Solution in Prevention of TAC Induced Neutropenia
Clinical trial NCT04227990 · COMPLETED
Trial details
- NCT number
- NCT04227990
- Sponsor
- BeyondSpring Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-10-15
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.